Home › Galapagos, GSK successfully conclude phase 2a study of skin disease drug
 

Keywords :   


Galapagos, GSK successfully conclude phase 2a study of skin disease drug

2014-04-17 09:46:53| Biotech - Topix.net

Belgian biotech group Galapagos NV on Thursday said it has successfully concluded the phase 2a study of a skin disease drug it is developing with Britain's GlaxoSmithKline PLC.

Tags: study skin drug phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »